AtriCure, Inc. (ATRC)
39.56
-0.62
(-1.54%)
USD |
NASDAQ |
Dec 31, 16:00
39.51
-0.05
(-0.13%)
After-Hours: 20:00
AtriCure Research and Development Expense (TTM): 89.62M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Abbott Laboratories | 2.897B |
| Alphatec Holdings, Inc. | 76.78M |
| Boston Scientific Corp. | 1.943B |
| iRhythm Technologies, Inc. | 82.64M |
| Perspective Therapeutics, Inc. | 61.22M |